home / stock / avhhl / avhhl short
Short Information | Avita Therapeutics (OTCMKTS:AVHHL)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 17,925 |
Total Actual Volume | 29,336 |
Short Trends | |
---|---|
Cover Days | 4 |
Short Days | 15 |
No Change Days | 1 |
Averages | |
---|---|
Average Short Volume | 896 |
Average Short Percentage | 74.55% |
Is there a AVHHL Short Squeeze or Breakout about to happen?
See the AVHHL Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
02-02-2024 | $3.24 | $3.45 | $3.45 | $3.1 | 1,275 | 100 | 7.84% |
01-04-2024 | $2.77 | $2.77 | $2.77 | $2.77 | 400 | 400 | 100% |
10-06-2023 | $2.185 | $2.185 | $2.185 | $2.185 | 1,000 | 1,000 | 100% |
08-24-2023 | $3.12 | $3.12 | $3.12 | $3.12 | 500 | 500 | 100% |
08-22-2023 | $3.45 | $3.45 | $3.45 | $3.45 | 100 | 100 | 100% |
08-15-2023 | $3.55 | $3.55 | $3.55 | $3.55 | 250 | 200 | 80% |
07-17-2023 | $3.55 | $4.01 | $4.01 | $3.55 | 3,300 | 2,448 | 74.18% |
07-14-2023 | $3.5 | $3.55 | $3.55 | $3.5 | 3,827 | 3,244 | 84.77% |
04-11-2023 | $2.5 | $2.7 | $2.7 | $2.5 | 1,650 | 398 | 24.12% |
11-23-2022 | $1.3 | $1.3 | $1.3 | $1.3 | 1,750 | 1,750 | 100% |
07-26-2022 | $1 | $1 | $1 | $1 | 225 | 225 | 100% |
03-30-2022 | $2.01 | $2 | $2.01 | $2 | 5,670 | 1,200 | 21.16% |
02-09-2022 | $2.25 | $2.25 | $2.25 | $2.25 | 300 | 300 | 100% |
11-05-2021 | $3.4 | $3.4 | $3.4 | $3.4 | 2,625 | 2,625 | 100% |
11-04-2021 | $3.5 | $3.5 | $3.5 | $3.5 | 1,269 | 400 | 31.52% |
08-30-2021 | $3.85 | $2.9 | $4 | $2.9 | 1,129 | 644 | 57.04% |
07-19-2021 | $2.7 | $2.7 | $2.7 | $2.7 | 484 | 451 | 93.18% |
07-12-2021 | $3.85 | $3.85 | $3.85 | $3.85 | 200 | 200 | 100% |
06-25-2021 | $3.9 | $4 | $4.1 | $3.9 | 2,732 | 1,284 | 47% |
05-19-2021 | $4 | $4.1 | $4.1 | $4 | 650 | 456 | 70.15% |
News, Short Squeeze, Breakout and More Instantly...
Avita Therapeutics Company Name:
AVHHL Stock Symbol:
OTCMKTS Market:
VALENCIA, Calif., April 15, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today announced that it will report its first quarter 2024 financia...
VALENCIA, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today announced an update to its expected commercial revenue for th...
VALENCIA, Calif., Feb. 29, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today announced it has submitted its response to the U.S. Food and D...